Cargando…

Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer

SIMPLE SUMMARY: The key factor in preventing premature death from cancer is an early and accurate diagnosis. While common diagnostic procedures are successful in the detection and rough description of a tumor mass, a deeper insight into cancer’s molecular features is needed to optimize the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Combes, Guillaume F., Vučković, Ana-Marija, Perić Bakulić, Martina, Antoine, Rodolphe, Bonačić-Koutecky, Vlasta, Trajković, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393257/
https://www.ncbi.nlm.nih.gov/pubmed/34439360
http://dx.doi.org/10.3390/cancers13164206
_version_ 1783743691478794240
author Combes, Guillaume F.
Vučković, Ana-Marija
Perić Bakulić, Martina
Antoine, Rodolphe
Bonačić-Koutecky, Vlasta
Trajković, Katarina
author_facet Combes, Guillaume F.
Vučković, Ana-Marija
Perić Bakulić, Martina
Antoine, Rodolphe
Bonačić-Koutecky, Vlasta
Trajković, Katarina
author_sort Combes, Guillaume F.
collection PubMed
description SIMPLE SUMMARY: The key factor in preventing premature death from cancer is an early and accurate diagnosis. While common diagnostic procedures are successful in the detection and rough description of a tumor mass, a deeper insight into cancer’s molecular features is needed to optimize the treatment and increase the chances of survival. Nanotechnology can aid the molecular diagnostics of cancers through a design of nanomaterials that can simultaneously recognize specific cancer-associated molecules, so-called tumor biomarkers, and allow for their visualization by different imaging techniques. With a recent explosion in the production of various nanomaterials, the selection of the most suitable nanomaterial for tumor biomarker detection becomes a challenge. In this article, we review recent advances in the molecular diagnostics of cancer using nanotechnology and focus on liganded noble metal quantum nanoclusters, a class of ultrasmall nanomaterials with distinctive structural and optical properties, as tools in tumor biomarker detection. ABSTRACT: Cancer is one of the leading causes of premature death, and, as such, it can be prevented by developing strategies for early and accurate diagnosis. Cancer diagnostics has evolved from the macroscopic detection of malignant tissues to the fine analysis of tumor biomarkers using personalized medicine approaches. Recently, various nanomaterials have been introduced into the molecular diagnostics of cancer. This has resulted in a number of tumor biomarkers that have been detected in vitro and in vivo using nanodevices and corresponding imaging techniques. Atomically precise ligand-protected noble metal quantum nanoclusters represent an interesting class of nanomaterials with a great potential for the detection of tumor biomarkers. They are characterized by high biocompatibility, low toxicity, and suitability for controlled functionalization with moieties specifically recognizing tumor biomarkers. Their non-linear optical properties are of particular importance as they enable the visualization of nanocluster-labeled tumor biomarkers using non-linear optical techniques such as two-photon-excited fluorescence and second harmonic generation. This article reviews liganded nanoclusters among the different nanomaterials used for molecular cancer diagnosis and the relevance of this new class of nanomaterials as non-linear optical probe and contrast agents.
format Online
Article
Text
id pubmed-8393257
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83932572021-08-28 Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer Combes, Guillaume F. Vučković, Ana-Marija Perić Bakulić, Martina Antoine, Rodolphe Bonačić-Koutecky, Vlasta Trajković, Katarina Cancers (Basel) Review SIMPLE SUMMARY: The key factor in preventing premature death from cancer is an early and accurate diagnosis. While common diagnostic procedures are successful in the detection and rough description of a tumor mass, a deeper insight into cancer’s molecular features is needed to optimize the treatment and increase the chances of survival. Nanotechnology can aid the molecular diagnostics of cancers through a design of nanomaterials that can simultaneously recognize specific cancer-associated molecules, so-called tumor biomarkers, and allow for their visualization by different imaging techniques. With a recent explosion in the production of various nanomaterials, the selection of the most suitable nanomaterial for tumor biomarker detection becomes a challenge. In this article, we review recent advances in the molecular diagnostics of cancer using nanotechnology and focus on liganded noble metal quantum nanoclusters, a class of ultrasmall nanomaterials with distinctive structural and optical properties, as tools in tumor biomarker detection. ABSTRACT: Cancer is one of the leading causes of premature death, and, as such, it can be prevented by developing strategies for early and accurate diagnosis. Cancer diagnostics has evolved from the macroscopic detection of malignant tissues to the fine analysis of tumor biomarkers using personalized medicine approaches. Recently, various nanomaterials have been introduced into the molecular diagnostics of cancer. This has resulted in a number of tumor biomarkers that have been detected in vitro and in vivo using nanodevices and corresponding imaging techniques. Atomically precise ligand-protected noble metal quantum nanoclusters represent an interesting class of nanomaterials with a great potential for the detection of tumor biomarkers. They are characterized by high biocompatibility, low toxicity, and suitability for controlled functionalization with moieties specifically recognizing tumor biomarkers. Their non-linear optical properties are of particular importance as they enable the visualization of nanocluster-labeled tumor biomarkers using non-linear optical techniques such as two-photon-excited fluorescence and second harmonic generation. This article reviews liganded nanoclusters among the different nanomaterials used for molecular cancer diagnosis and the relevance of this new class of nanomaterials as non-linear optical probe and contrast agents. MDPI 2021-08-21 /pmc/articles/PMC8393257/ /pubmed/34439360 http://dx.doi.org/10.3390/cancers13164206 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Combes, Guillaume F.
Vučković, Ana-Marija
Perić Bakulić, Martina
Antoine, Rodolphe
Bonačić-Koutecky, Vlasta
Trajković, Katarina
Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer
title Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer
title_full Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer
title_fullStr Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer
title_full_unstemmed Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer
title_short Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer
title_sort nanotechnology in tumor biomarker detection: the potential of liganded nanoclusters as nonlinear optical contrast agents for molecular diagnostics of cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393257/
https://www.ncbi.nlm.nih.gov/pubmed/34439360
http://dx.doi.org/10.3390/cancers13164206
work_keys_str_mv AT combesguillaumef nanotechnologyintumorbiomarkerdetectionthepotentialofligandednanoclustersasnonlinearopticalcontrastagentsformoleculardiagnosticsofcancer
AT vuckovicanamarija nanotechnologyintumorbiomarkerdetectionthepotentialofligandednanoclustersasnonlinearopticalcontrastagentsformoleculardiagnosticsofcancer
AT pericbakulicmartina nanotechnologyintumorbiomarkerdetectionthepotentialofligandednanoclustersasnonlinearopticalcontrastagentsformoleculardiagnosticsofcancer
AT antoinerodolphe nanotechnologyintumorbiomarkerdetectionthepotentialofligandednanoclustersasnonlinearopticalcontrastagentsformoleculardiagnosticsofcancer
AT bonacickouteckyvlasta nanotechnologyintumorbiomarkerdetectionthepotentialofligandednanoclustersasnonlinearopticalcontrastagentsformoleculardiagnosticsofcancer
AT trajkovickatarina nanotechnologyintumorbiomarkerdetectionthepotentialofligandednanoclustersasnonlinearopticalcontrastagentsformoleculardiagnosticsofcancer